Date of Creation
First Year Seminar
Despite the human immune system, cancer thrives in an extremely hostile environment. Cancer is the second most common cause of death in the U.S. with about 600,000 deaths every year, and cancer is expected to surpass heart disease as the most common cause of death in the U.S. Immune checkpoint inhibitors are a novel and promising therapeutic for treating cancer in its late stages.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Cherubino, Matthew A., "Immune Checkpoints in Cancer Treatment" (2018). Student Publications. 677.